<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font17">al., </span>
   <span class="font15">(). </span>
   <span class="font13">with </span>
   <span class="font13">(), </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">al. </span>
   <span class="font13">for </span>
   <span class="font12">â€". </span>
   <span class="font12">NCT, </span>
   <span class="font12">COVID- </span>
   <span class="font12">The </span>
   <span class="font11">viral </span>
   <span class="font11">which </span>
   <span class="font11">NCT </span>
   <span class="font11">response </span>
   <span class="font11">clinical </span>
   <span class="font11">has </span>
   <span class="font11">are </span>
   <span class="font11">patients </span>
   <span class="font11">treatment </span>
   <span class="font11">against </span>
   <span class="font11">been </span>
   <span class="font11">cells </span>
   <span class="font11">have </span>
   <span class="font11">immune </span>
   <span class="font11">MSC </span>
   <span class="font11">{background </span>
   <span class="font11">ACE </span>
   <span class="font11">severe </span>
   <span class="font11">other </span>
   <span class="font11">therapeutic </span>
   <span class="font11">this </span>
   <span class="font11">coronavirus </span>
   <span class="font10">respiratory </span>
   <span class="font10">that </span>
   <span class="font10">China </span>
   <span class="font10">RNA </span>
   <span class="font10">human </span>
   <span class="font10">trial </span>
   <span class="font10">could </span>
   <span class="font10">margin </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">through </span>
   <span class="font10">from </span>
   <span class="font10">vaccine </span>
   <span class="font10">{border-style </span>
   <span class="font10">also </span>
   <span class="font10">role </span>
   <span class="font10">ChiCTR, </span>
   <span class="font10">acute </span>
   <span class="font10">not </span>
   <span class="font10">px;} </span>
   <span class="font10">their </span>
   <span class="font10">these </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">protein </span>
   <span class="font10">administration </span>
   <span class="font10">drugs </span>
   <span class="font10">its </span>
   <span class="font10">potential </span>
   <span class="font10">receptor </span>
   <span class="font10">infection </span>
   <span class="font10">Cell </span>
   <span class="font10">antiviral </span>
   <span class="font10">between </span>
   <span class="font10">cell </span>
   <span class="font10">enzyme </span>
   <span class="font10">protease </span>
   <span class="font10">study </span>
   <span class="font10">trials </span>
   <span class="font10">was </span>
   <span class="font10">well </span>
   <span class="font10">Human </span>
   <span class="font10">Med. </span>
   <span class="font10">entry </span>
   <span class="font10">inflammatory </span>
   <span class="font10">receptors </span>
   <span class="font10">syndrome </span>
   <span class="font10">used </span>
   <span class="font10">vaccines </span>
   <span class="font10">(ph </span>
   <span class="font10">./S-()- </span>
   <span class="font10">SUA </span>
   <span class="font10">antibodies </span>
   <span class="font10">associated </span>
   <span class="font10">but </span>
   <span class="font10">can </span>
   <span class="font10">complex </span>
   <span class="font10">data </span>
   <span class="font10">molecules </span>
   <span class="font10">plasma </span>
   <span class="font10">remdesivir </span>
   <span class="font10">target </span>
   <span class="font10">use </span>
   <span class="font10">(); </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">SARS </span>
   <span class="font10">currently </span>
   <span class="font10">stem </span>
   <span class="font10">still </span>
   <span class="font10">virus </span>
   <span class="font10">years </span>
   <span class="font10">(NCT, </span>
   <span class="font10">./s--- </span>
   <span class="font10">Clinical </span>
   <span class="font10">Infect. </span>
   <span class="font10">Nevertheless, </span>
   <span class="font10">cytokine </span>
   <span class="font10">host </span>
   <span class="font10">neutralizing </span>
   <span class="font10">phase </span>
   <span class="font10">proteins </span>
   <span class="font10">release </span>
   <span class="font10">side </span>
   <span class="font10">spike </span>
   <span class="font10">therapy </span>
   <span class="font10">various </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">FDA </span>
   <span class="font10">Hence, </span>
   <span class="font10">Lancet </span>
   <span class="font10">convalescent </span>
   <span class="font10">cytokines </span>
   <span class="font10">disease </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">experimental </span>
   <span class="font10">fusion </span>
   <span class="font10">new </span>
   <span class="font10">response, </span>
   <span class="font10">results </span>
   <span class="font10">risk </span>
   <span class="font10">safety </span>
   <span class="font10">specific </span>
   <span class="font10">./... </span>
   <span class="font10">Additionally, </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Clin. </span>
   <span class="font10">Engl. </span>
   <span class="font10">GM-CSF </span>
   <span class="font10">IFN </span>
   <span class="font10">IL- </span>
   <span class="font10">Patients </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">Trial </span>
   <span class="font10">already </span>
   <span class="font10">antibody </span>
   <span class="font10">during </span>
   <span class="font10">high </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibition </span>
   <span class="font10">lung </span>
   <span class="font10">monoclonal </span>
   <span class="font10">more </span>
   <span class="font10">multiple </span>
   <span class="font10">px; </span>
   <span class="font10">synthesis </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">./NEJMoa </span>
   <span class="font10">ARDS </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Respiratory </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Table </span>
   <span class="font10">This </span>
   <span class="font10">Virol. </span>
   <span class="font10">activity </span>
   <span class="font10">approved </span>
   <span class="font10">authors </span>
   <span class="font10">benefit </span>
   <span class="font10">cases </span>
   <span class="font10">combination </span>
   <span class="font10">control </span>
   <span class="font10">critical </span>
   <span class="font10">current </span>
   <span class="font10">development </span>
   <span class="font10">drug </span>
   <span class="font10">efficiency </span>
   <span class="font10">either </span>
   <span class="font10">endosomal </span>
   <span class="font10">font-size </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">immunity </span>
   <span class="font10">mAb </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">namely </span>
   <span class="font10">pandemic </span>
   <span class="font10">pathogenic </span>
   <span class="font10">preliminary </span>
   <span class="font10">regarding </span>
   <span class="font10">response. </span>
   <span class="font10">therapies </span>
   <span class="font10">there </span>
   <span class="font10">viruses </span>
   <span class="font10">while </span>
   <span class="font10">(NCT) </span>
   <span class="font10">Cells </span>
   <span class="font10">Currently, </span>
   <span class="font10">Dis. </span>
   <span class="font10">NCT) </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Sci. </span>
   <span class="font10">Severe </span>
   <span class="font10">Still, </span>
   <span class="font10">Syndrome </span>
   <span class="font10">angiotensin </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">article </span>
   <span class="font10">b). </span>
   <span class="font10">cardiac </span>
   <span class="font10">case </span>
   <span class="font10">cellular </span>
   <span class="font10">certain </span>
   <span class="font10">cord-derived </span>
   <span class="font10">double; </span>
   <span class="font10">expressing </span>
   <span class="font10">further </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">into </span>
   <span class="font10">intravenous </span>
   <span class="font10">large </span>
   <span class="font10">mechanisms </span>
   <span class="font10">most </span>
   <span class="font10">pneumonia </span>
   <span class="font10">pulmonary </span>
   <span class="font10">replication </span>
   <span class="font10">require </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">study. </span>
   <span class="font10">targeting </span>
   <span class="font10">transcription </span>
   <span class="font10">translation </span>
   <span class="font10">would </span>
   <span class="font10">(NCT). </span>
   <span class="font10">(Wang </span>
   <span class="font10">./JVI.- </span>
   <span class="font10">Acute </span>
   <span class="font10">April </span>
   <span class="font10">Care </span>
   <span class="font10">ChiCTR </span>
   <span class="font10">ChinaÂ </span>
   <span class="font10">Chinese </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Covid-. </span>
   <span class="font10">Drug </span>
   <span class="font10">Drugs </span>
   <span class="font10">Entry </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">IFN-I </span>
   <span class="font10">Int. </span>
   <span class="font10">International </span>
   <span class="font10">June </span>
   <span class="font10">Medicine </span>
   <span class="font10">Nat. </span>
   <span class="font10">Receptor </span>
   <span class="font10">Study </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">Therapy </span>
   <span class="font10">Treatment </span>
   <span class="font10">Umbilical </span>
   <span class="font10">Vaccine </span>
   <span class="font10">Vaccines </span>
   <span class="font10">Viral </span>
   <span class="font10">Wang </span>
   <span class="font10">ability </span>
   <span class="font10">agents </span>
   <span class="font10">autophagy </span>
   <span class="font10">best </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">candidate </span>
   <span class="font10">cohort </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">derived </span>
   <span class="font10">distress </span>
   <span class="font10">due </span>
   <span class="font10">early </span>
   <span class="font10">efficient </span>
   <span class="font10">endocytosis </span>
   <span class="font10">epithelial </span>
   <span class="font10">especially </span>
   <span class="font10">even </span>
   <span class="font10">expression </span>
   <span class="font10">induce </span>
   <span class="font10">inflammation </span>
   <span class="font10">inhibitor </span>
   <span class="font10">interaction </span>
   <span class="font10">interferon </span>
   <span class="font10">invasion </span>
   <span class="font10">novel </span>
   <span class="font10">numerous </span>
   <span class="font10">ongoing </span>
   <span class="font10">potentially </span>
   <span class="font10">prevent </span>
   <span class="font10">production </span>
   <span class="font10">proposed </span>
   <span class="font10">protective </span>
   <span class="font10">proved </span>
   <span class="font10">recent </span>
   <span class="font10">recombinant </span>
   <span class="font10">recorded </span>
   <span class="font10">related </span>
   <span class="font10">remains </span>
   <span class="font10">remdesivir, </span>
   <span class="font10">reported </span>
   <span class="font10">responses </span>
   <span class="font10">safe </span>
   <span class="font10">same </span>
   <span class="font10">should </span>
   <span class="font10">solid; </span>
   <span class="font10">time </span>
   <span class="font10">tissue </span>
   <span class="font10">trial, </span>
   <span class="font10">type </span>
   <span class="font10">unclear </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Table </span>
   <span class="font10">Agents </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Biol. </span>
   <span class="font10">ChAdOx </span>
   <span class="font10">China. </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Diseases </span>
   <span class="font10">Health </span>
   <span class="font10">Hospitalized </span>
   <span class="font10">IFN-alpha </span>
   <span class="font10">IgG </span>
   <span class="font10">Infectious </span>
   <span class="font10">Inhibition </span>
   <span class="font10">Iran </span>
   <span class="font10">MERS </span>
   <span class="font10">Med., </span>
   <span class="font10">Monteil </span>
   <span class="font10">NCT). </span>
   <span class="font10">National </span>
   <span class="font10">Other </span>
   <span class="font10">Phase </span>
   <span class="font10">RECOVERY </span>
   <span class="font10">Registry </span>
   <span class="font10">Russian </span>
   <span class="font10">Spike </span>
   <span class="font10">Steps </span>
   <span class="font10">Targets </span>
   <span class="font10">United </span>
   <span class="font10">With </span>
   <span class="font10">according </span>
   <span class="font10">alternative </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">azithromycin </span>
   <span class="font10">beginning </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">chloroquine </span>
   <span class="font10">clathrin-mediated </span>
   <span class="font10">cleavage </span>
   <span class="font10">compassionate </span>
   <span class="font10">controlled </span>
   <span class="font10">courier; </span>
   <span class="font10">cycle </span>
   <span class="font10">did </span>
   <span class="font10">electroporation </span>
   <span class="font10">em; </span>
   <span class="font10">epitopes </span>
   <span class="font10">essential </span>
   <span class="font10">expected </span>
   <span class="font10">factors </span>
   <span class="font10">following </span>
   <span class="font10">form </span>
   <span class="font10">genes </span>
   <span class="font10">group </span>
   <span class="font10">highly </span>
   <span class="font10">humoral </span>
   <span class="font10">hydroxychloroquine, </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">important </span>
   <span class="font10">injury </span>
   <span class="font10">investigational </span>
   <span class="font10">involved </span>
   <span class="font10">kinase </span>
   <span class="font10">known </span>
   <span class="font10">limited </span>
   <span class="font10">load </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">lopinavir/ritonavir, </span>
   <span class="font10">mAb) </span>
   <span class="font10">mammalian </span>
   <span class="font10">membrane </span>
   <span class="font10">mortality </span>
   <span class="font10">nCoV- </span>
   <span class="font10">play </span>
   <span class="font10">plays </span>
   <span class="font10">polymerase </span>
   <span class="font10">protection </span>
   <span class="font10">pt;} </span>
   <span class="font10">published </span>
   <span class="font10">randomized </span>
   <span class="font10">rapid </span>
   <span class="font10">received </span>
   <span class="font10">recently </span>
   <span class="font10">respect, </span>
   <span class="font10">responsible </span>
   <span class="font10">serine </span>
   <span class="font10">serum </span>
   <span class="font10">short </span>
   <span class="font10">shown </span>
   <span class="font10">since </span>
   <span class="font10">spread </span>
   <span class="font10">stage </span>
   <span class="font10">storm </span>
   <span class="font10">structural </span>
   <span class="font10">system </span>
   <span class="font10">targeted </span>
   <span class="font10">targets </span>
   <span class="font10">transmembrane </span>
   <span class="font10">trial. </span>
   <span class="font10">trigger </span>
   <span class="font10">were </span>
   <span class="font10">yet </span>
  </p>
 </body>
</html>
